Quanbeck A, Johnson RA, Saha-Muldowney M, Resnik F, Hirschfield S, Meline RE, Mahoney JE. Encouraging the scale-up of proven interventions: Infrastructure development for the ‘Evidence-to-Implementation’ Award. Journal of Clinical and Translational Science Cambridge University Press: 26 July 2021, pp. 1-20. Available online at
Quanbeck A, Almirall D, Jacobson N, Brown RT, Landeck JK, Madden L, Cohen A, Deyo BMF, Robinson J, Johnson RA, Schumacher N. The Balanced Opioid Initiative: protocol for a clustered, sequential, multiple-assignment randomized trial to construct an adaptive implementation strategy to improve guideline-concordant opioid prescribing in primary care. Implementation Science 2020; 15:26. doi: 10.1186/s13012-020-00990-4
Quanbeck A, Mahoney J, Kies K, Judge K, Smith M. Building capacity for dissemination and implementation to maximize research impact in a CTSA: The University of Wisconsin story. Journal of Clinical and Translational Science. 2020:1-7. doi: 10.1017/cts.2020.3.
Quanbeck A, Mahoney J, Kies, K, Judge K, Smith M. Developing Dissemination and Implementation Capacity Within a CTSA: A Toolkit. University of Wisconsin – Madison School of Medicine and Public Health – Department of Family Medicine and Community Health, Health Innovation Program. Madison, WI; 2019. Available at: www.hipxchange.org/DevelopD&I.
Quanbeck A. Using stakeholder values to promote implementation of an evidence-based mobile health intervention for addiction treatment in primary care settings. JMIR Mhealth Uhealth. 2019;7(6):e13301. doi:10.2196/13301.
Pandhi N, Jacobson N, Crowder M, Quanbeck A, Hass M, Davis S. Engaging patients in primary care quality improvement initiatives: facilitators and barriers. Am J Med Qual. Epub ahead of print: 18 April 2019. doi: 10.1177/1062860619842938.
Quanbeck A. Decision-framing to Incorporate Stakeholder Perspectives in Implementation toolkit. University of Wisconsin – Madison Department of Family Medicine & Community Health. Madison, WI; 2019. Available at: https://www.hipxchange.org/ImplementationDecisionMaking
Molfenter T, Fitzgerld M, Jacobson N, McCarty D, Quanbeck A, Zehner M. Barriers to Buprenorphine Expansion in Ohio A Time Elapsed Qualitative Study. J Psychoactive Drugs. 2019. Epub ahead of print: 7 Feburary 2019. doi: 10.1080/02791072.2019.1566583.
Jacobson N, Johnson R, Deyo B, Alagoz E, Quanbeck A. Systems consultation for opioid prescribing in primary care: a qualitative study of adaptation. BMJ Qual Saf. 2018;0:1-8.
Madden LM, Farnum SO, Eggert KF, Quanbeck AR, Freeman RM, Ball SA, Schottenfeld RS, Shi JM, Savage ME, Barry DT. An investigation of an open-access model for scaling up methadone maintenance treatment. Addiction. 2018;113(8):1450-8.
Molfenter T, Sherbeck C, Starr S, Kim JS, Zehner M, Quanbeck A, Jacobson N, McCarty D. Payer policy behavior towards opioid pharmacotherapy treatment in Ohio. J Addict Med. 2018;12(2):85-91.
Quanbeck A, Gustafson DH, Marsch LA, Chih MY, Kornfield R, McTavish F, Johnson R, Brown RT, Mares ML, Shah DV. Implementing a mobile health system to integrate the treatment of addiction into primary care: a hybrid implementation-effectiveness study. J Med Internet Res. 2018; 20(1):e37.
Top 5% of all research outputs (Altmetric).
Alagoz E, Chih MY, Hitchcock M, Brown R, Quanbeck A. The use of external change agents to promote quality improvement and organizational change in healthcare organizations: a systematic review. BMC Health Serv Res. 2018;18(1):42.
Quanbeck A, Brown RT, Zgierska AE, Jaconbson N, Robinson JM, Johnson RA, Deyo BM, Madden L, Tuan WJ, Alagoz E. A randomized matched-pairs study of feasibility, acceptability, and effectiveness of systems consultation: a novel implementation strategy for adopting clinical guidelines for opioid prescribing in primary care. Implement Sci. 2018;13(1):21.
Ranks in 87th percentile (Altmetric).
McKay JR, Gustafson DH, Ivey M, McTavish F, Pe-Romashko K, Curtis B, Oslin DA, Polsky D, Quanbeck A, Lynch KG. Effects of automated smartphone mobile recovery support and telephone continuing care in the treatment of alcohol use disorder: study protocol for a randomized controlled trial. Trials. 2018;19:82.
Brown R, Deyo B, Riley C, Quanbeck A, Glass JE, Turpin R, Hetzel S, Nicholas C, Cruz M, Agarwal S. Screening in trauma for opioid miuse prevention (STOMP): study protocol for the development of an opioid risk screening tool for victims of injury. Addict Sci Clin Pract. 2017;12(1):28.
Gustafson DH, DuBenske LL, Atwood AK, Chih MY, Johnson RA, McTavish F, Quanbeck A, Brown RL, Cleary JF, Shah D. Reducing symptom distress in patients with advanced cancer using an e-alert system for caregivers: pooled analysis of two randomized clinical trials. J Med Internet Res. 2017;19(11):e354.
Glass JE, McKay JR, Gustafson DH, Kornfield R, Rathouz PJ, McTavish FM, Atwood AK, Isham A, Quanbeck A, Shad D. Treatment seeking as a mechanism of change in a randomized controlled trial of a mobile health intervention to support recovery from alcohol use disorders. J Subst Abuse Treat. 2017;77:57-66.
Gustafson DH Sr, Landucci G, McTavish F, Kornfield R, Johnson RA, Mares ML, Westergaard RP, Quanbeck A, Alagoz E, Pe-Romashko K, Thomas C, Shah D. The effect of bundling medication-assisted treatment for opioid addiction with mHealth: study protocol for a randomized clinical trial. Trails. 2016;17(1):592.
Mares ML, Gustafson DH, Glass JE, Quanbeck A, McDowell H, McTavish F, Atwood AK, Marsch LA, Thomas C, Shah D, Brown R, Isham A, Nealon MJ, Ward V. Implementing an mHealth system for substance use disorders in primary care: a mixed methods study of clinicians’ initial expectations and first year experiences. BMC Med Inform Decis Mak. 2016;16(1):126.
Quanbeck A, Brown RT, Zgierska AE, Johnson RA, Robinson JM, Jacobson N. Systems consultation: protocol for a novel implementation strategy designed to promote evidence-based practice in primary care. Health Res Policy Syst. 2016;14:8.
Alagoz E, Johnson K, Quanbeck A, Gustafson D. Addiction in the older patient: Technology-based Interventions for Late-Life Addiction (Chapter 11). Sullivan M, Levin F, editors. London: Oxford University Press; 2016.
Grazier KL, Quanbeck AR, Oruongo J, Robinson J, Ford JH 2nd, McCarty D, Pulvermacher A, Johnson RA, Gustafson DH. What influences participation in QI? A randomized trial of addiction treatment organizations. J Helathc Qual. 2015;37(6):342-53.
Johnson K, Quanbeck A, Maus A, Gustafson DH, Dearing JW. Influence networks among substance abuse treatment clinics: implications for the dissemination of innovations. Transl Behav Med. 2015;5(3):260-8.
Gustafson DH Sr, McTavish F, Gustafson DH Jr, Mahoney JE, Johnson RA, Lee JD, Quanbeck A, Atwood AK, Isham A, Veeramani R, Clemson L, Shah D. The effect of an information and communication technology (ICT) on older adults’ quality of life: study protocol for a randomized control trial. Trials. 2015;16:191.
Molfenter T, Sherbeck C, Zehner M, Quanbeck A, McCarty D, Kim JS, Starr S. Implementation buprenorphine in addiction treatment: payer and provider perspectives in Ohio. Subst Abuse Treat Prev Policy. 2015;10:13.
Quanbeck AR, Gustafson DH, Marsch LA, McTavish F, Brown RT, Mares ML, Johnson R, Glass JE, Atwood AK, McDowell H. Integrating addiction treatment into primary care using mobile health technology: protocol for an implementation research study. Implement Sci. 2014;9:65.
Quanbeck A, Chih MY, Isham A, Gustafson D. Mobile delivery of treatment for alcohol use disorders: a review of the literature. Alcohol Res. 2014;36(1):111-22.
Gustafson DH, Quanbeck AR, Robinson JM, Ford JH 2nd, Pulvermacher A, French MT, McConnell KJ, Batalden PB, Hoffman KA, McCarty D. Which elements of improvement collaboratives are most effective? A cluster-randomized trial. Addiction 2013;108(6):1145-57.
Molfenter T, Kim JS, Quanbeck A, Patel-Porter T, Starr S, McCarty D. Testing use of payers to facilitate evidence-based practice adoption: protocol for a cluster-randomized trial. Implement Sci. 2013;8:50.
Quanbeck A, Wheelock A, Ford JH 2nd, Pulvermacher A, Capoccia V, Gustafson D. Examining access to addiction treatment: scheduling processes and barriers. J Subst Abuse Treat. 2013;44(3):343-8.
Quanbeck AR, Madden L, Edmundson E, Ford JH 2nd, McConnell KJ, McCarty D, Gustafson DH. A business case for quality improvement in addiction treatment evidence from the NIATx collaborative. J Behav Health Serv Res. 2012;39(1):91-100.
Hoffman KA, Quanbeck A, Ford JH 2nd, Wrede F, Wright D, Lambert-Wacey D, Chvojka P, Hanchett A, McCarty D. Improving substance abuse data systems to measure ‘waiting time to treatment’: lessons learned from a quality improvement initiative. Health Informatics J. 2011;17(4):256-65.
Quanbeck AR, Gustafson DH, Ford JH 2nd, Pulvermacher A, French MT, McConnell KJ, McCarty D. Disseminating quality improvement study protocol for a large cluster-randomized trial. Implement Sci. 2011;6:44.
Quanbeck A, Lang K, Enami K, Brown RL. A cost-benefit analysis of Wisconsin’s screening, brief intervention, and referral to treatment program: adding the employer’s perspective. WMJ 2010;109(1):9-14.
Quanbeck A. Managing your way to better addiction treatment outcomes. Behav Helathc 2009;29(9):34-5.
McConnell KJ, Hoffman KA, Quanbeck A, McCarty D. Management practices in substance abuse treatment programs. J Subst Abuse Treat 2009;37(1):79-89.